Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Rapp

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Surgical Infections|February 22, 2003
Emerging bacterial pathogens: a consensus of the scientific data and the risk for development of multiple organ dysfunction syndromeR P Rapp
The Annals of Pharmacotherapy|December 1, 1996
Comment: Vancomycin-resistant enterococciR P Rapp
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Comment: i.v. infusion devicesR P Rapp
The Annals of Pharmacotherapy|July 29, 1998
Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactionsR P Rapp
American Journal of Hospital Pharmacy|December 1, 1992
Rising price of amikacin sulfateR P Rapp
DICP : the Annals of Pharmacotherapy|September 1, 1989
Parenteral nutrition: 1989 and beyondR P Rapp
Clinical Pharmacy|February 1, 1987
Use of lidocaine to reduce pain associated with potassium chloride infusionsR P Rapp
American Journal of Hospital Pharmacy|November 1, 1987
Considering product features and costs in selecting a system for intermittent i.v. drug deliveryR P Rapp
Drug Intelligence & Clinical Pharmacy|February 1, 1985
Hospital intravenous drug administration in the era of prospective paymentR P Rapp
Pharmacotherapy|August 24, 1999
Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentrationR P Rapp
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Surgical Infections|February 22, 2003
Emerging bacterial pathogens: a consensus of the scientific data and the risk for development of multiple organ dysfunction syndromeR P Rapp
The Annals of Pharmacotherapy|December 1, 1996
Comment: Vancomycin-resistant enterococciR P Rapp
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Comment: i.v. infusion devicesR P Rapp
The Annals of Pharmacotherapy|July 29, 1998
Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactionsR P Rapp
American Journal of Hospital Pharmacy|December 1, 1992
Rising price of amikacin sulfateR P Rapp
DICP : the Annals of Pharmacotherapy|September 1, 1989
Parenteral nutrition: 1989 and beyondR P Rapp
Clinical Pharmacy|February 1, 1987
Use of lidocaine to reduce pain associated with potassium chloride infusionsR P Rapp
American Journal of Hospital Pharmacy|November 1, 1987
Considering product features and costs in selecting a system for intermittent i.v. drug deliveryR P Rapp
Drug Intelligence & Clinical Pharmacy|February 1, 1985
Hospital intravenous drug administration in the era of prospective paymentR P Rapp
Pharmacotherapy|August 24, 1999
Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentrationR P Rapp
Pageof 12